Oncovax-CL

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameOncovax-CL

Drug Alias NameJBT-2001b

ClassificationVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsLung NeoplasmsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesJenner Biotherapies

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsLung NeoplasmsColorectal Neoplasms

ATC CodeN/A